From the original announcement of acceptance of submission:Acrux...

  1. 38 Posts.
    lightbulb Created with Sketch. 7

    From the original announcement of acceptance of submission:

    Acrux has submitted an ANDA application to the FDA for Lidocaine 2.5% and Prilocaine
    2.5% cream, which has now been accepted for review
    • Annual sales for the product were US$35m as measured by IQVIA 1
    • The product is used as a topical anaesthetic
    • The announcement marks Acrux’s third product accepted for review by the FDA

    So... kinda? Bit of both?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
-0.001(5.00%)
Mkt cap ! $7.747M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $13.72K 687.1K

Buyers (Bids)

No. Vol. Price($)
6 618035 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 10000 1
View Market Depth
Last trade - 14.19pm 18/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.